betamethasone sodium phosphate has been researched along with Pink Eye in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deepthi, S; Jose, J | 1 |
| Aono, H; Hagiwara, Y; Imamura-Takai, M; Kato, M; Nakamura, M; Oda, T | 1 |
| Donshik, P; Kulvin, SM; Mckinley, P; Skowron, R | 1 |
1 trial(s) available for betamethasone sodium phosphate and Pink Eye
| Article | Year |
|---|---|
Treatment of chronic staphylococcal blepharoconjunctivitis with a new topical steroid anti-infective ophthalmic solution.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Blepharitis; Chronic Disease; Clinical Trials as Topic; Conjunctivitis; Double-Blind Method; Drug Combinations; Eyelid Diseases; Female; Gentamicins; Humans; Male; Middle Aged; Ophthalmic Solutions | 1983 |
2 other study(ies) available for betamethasone sodium phosphate and Pink Eye
| Article | Year |
|---|---|
Novel hydrogel-based ocular drug delivery system for the treatment of conjunctivitis.
Topics: Animals; Anti-Bacterial Agents; Betamethasone; Biological Availability; Chitosan; Conjunctivitis; Disease Models, Animal; Drug Delivery Systems; Eye Infections; Glucocorticoids; Hydrogels; Neomycin; Poloxamer; Rabbits | 2019 |
Beneficial pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Benzofurans; Benzoxazines; Betamethasone; Carrageenan; Cats; Cell Line, Tumor; Cells, Cultured; Conjunctivitis; Conjunctivitis, Allergic; Dexamethasone; Disease Models, Animal; Glucocorticoids; Humans; Intraocular Pressure; Male; Ophthalmic Solutions; Rats; Rats, Inbred BN; Rats, Wistar; Receptors, Glucocorticoid; Toxicity Tests; Transcriptional Activation | 2011 |